Tag: complete revascularization

PCI vs CABG in Patients with Unprotected Left Main Coronary Artery Disease

Key Takeaways

  • This meta-analysis evaluated 6 randomized controlled trials to determine outcome differences between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) among patients with unprotected left main coronary artery disease ([ULMCAD] n = 4686).
  • Compared with CABG, PCI correlated with significantly lower rates of 30-day stroke (P = 0.007), death or MI (P = 0.04), or all-cause death, MI, or stroke (P = 0.01).
  • In the PCI group, there was a significantly lower rate of 30-day stroke incidence (P = 0.007) and all-cause death, MI, or stroke (P = 0.01).
  • The authors found no significant difference in outcomes at long-term follow-up (median 39 months) between the two groups.
Reference: Palmerini T et al. Am Heart J. 2017;190:54-63.
Continue readingPCI vs CABG in Patients with Unprotected Left Main Coronary Artery Disease

Percutaneous Revascularization for Ischemic Cardiomyopathy

Dr. Michael Wyman discusses clinical and anatomic considerations and important concepts on revascularization and need for hemodynamic support in patients with ischemic cardiomyopathy. Subscribe, tweet this or join the conversation by following us on Twitter: @ProtectedPCI. Related Content: How a High-Risk PCI Patient with Advanced Cardiomyopathy was Completely Revascularized University Hospitals Cleveland Medical Center Protected … Continue reading “Percutaneous Revascularization for Ischemic Cardiomyopathy”

A Compelling Case for Revascularization: Specialist Opinion by Dr. Marty Leon

Dr. Marty Leon outlines the important role of hemodynamic support for complete revascularization in CHIP patients. Subscribe, or join the conversation by following us on Twitter: @ProtectedPCI ICP-075-16 To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: www.protectedpci.com/indications-use-safety-information/

Complete vs Incomplete Revascularization in Multivessel Coronary Artery Disease

The goal of coronary artery disease (CAD) treatment is coronary revascularization and repair of cardiac perfusion. Subsequently, revascularization tends to reduce long-term mortality, yet very few data exist to show a definite benefit of complete revascularization (CR) vs incomplete revascularization (IR) in clinical practice.A study from the Journal of the American College of Cardiology has found that CR may be the most suitable revascularization method for patients with multivessel CAD. The study was a systematic review and meta-analysis of published studies (observational and randomized clinical trials) that compared CR vs IR in multivessel CAD. All-cause mortality was used as the primary outcome. Approximately 35 studies were identified, which included nearly 90,000 patients. Continue readingComplete vs Incomplete Revascularization in Multivessel Coronary Artery Disease

92 Year Old WWII Veteran Benefits from Protected PCI with Impella®

Dr. Ehrin Armstrong, Director, Interventional Cardiology at University of Colorado VA – Denver Veteran’s Administration Hospital, shares a Protected PCI case of a 92-year-old veteran of WWII who was revascularized and is now back to his daily activities, with Dr. Cathy Jeon. ProtectedPCI.com celebrates and thanks all U.S. veterans for their service. Tweet this, join … Continue reading “92 Year Old WWII Veteran Benefits from Protected PCI with Impella®”

Why Complete Revascularization Should be the Standard for Most High-Risk PCI Cases, Dr. Jeffrey Moses

Dr. Jeffrey Moses, Director of Interventional Cardiac Therapeutics at Columbia University Medical Center, NY and Director of Complex Coronary Interventions at St. Francis Hospital, has been a pioneer in developing the techniques and data to optimize complex PCI. At this year’s Hartzler Interventional Cardiology Symposium, Dr. Moses presents a strong case for why complete revascularization … Continue reading “Why Complete Revascularization Should be the Standard for Most High-Risk PCI Cases, Dr. Jeffrey Moses”

Complete Revascularization of 67-year old Heart Failure Patient

Tulane University School of Medicine’s Dr. Nidal Abi Rafeh shares a fascinating case of complete revascularization using Protected PCI and Impella. The case is also an example of the need for cardiologists and interventional cardiologist, in particular, to constantly develop skill sets. Tweet this or subscribe to be alerted of future case reviews.

Heart Team Recommends Protected PCI vs. Medical Management for Treatment of 3VD After Surgical Turn Down

Today’s case review comes from the University of Washington’s Dr. Ravi Hira, who presents a ProtectedPCI case involving three-vessel intervention. Dr. Hira is Assistant Professor and Director of the Acute Cardiac Catheterization Service at Harborview Medical Center. His case involves the complete revascularization of a patient, who was successfully released from the hospital in relatively … Continue reading “Heart Team Recommends Protected PCI vs. Medical Management for Treatment of 3VD After Surgical Turn Down”

Dr. George W. Vetrovec Discusses Completeness of Revascularization

Data is emerging to support the notion that leaving patients behind with un-revascularized territories may be a risk to be discussed with patients. The key challenge is to completely revascularize patients. Dr. George Vetrovec, Professor Emeritus of the Virginia Commonwealth University, shares his thoughts with ProtectedPCI.com’s Dr. Seth Bilazarian in the podcast below covering completeness … Continue reading “Dr. George W. Vetrovec Discusses Completeness of Revascularization”

Focus on Appropriate Use of PCI May Be Driving Underuse for Patients Who Might Benefit

The 26th annual 2015 Scripps Cardiovascular Interventions Conference began the preconference seminar on Tuesday, October 27 with a talk entitled “A Compelling Case for Complex PCI in the Modern Era” by Dr. James McCabe, Medical Director of the University of Washington Cardiac Catheterization Laboratory, University of Washington Medical Center, Seattle, Washington. Continue readingFocus on Appropriate Use of PCI May Be Driving Underuse for Patients Who Might Benefit